- Presentations
- 2
- Markets
- 1
Cometriq is a brand of Cabozantinib s-malate and Cabozantinib marketed by Exelixis, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Cabozantinib s-malate, Cabozantinib
- Brand owner
- Exelixis
- Registered in
- United States
- Strengths and forms
- 20 mg capsule, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cometriq 20 mg capsuleOral | Exelixis | US FDA | Available on request |
| Cometriq kit | Exelixis | US FDA | Available on request |
Equivalent brands
Other brands of Cabozantinib s-malate and Cabozantinib.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cometriq
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.